Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
HIV Eradication: One Step Closer
Life Expectancy With HIV Increases Dramatically
Mouth Full of Problems: A Crisis in HIV Dental Care
New Technology Finds Meds That Might Flush Out Hidden HIV Reservoirs
New Hope for HIV Eradication
Personalized Therapeutic Vaccine Shows Promise
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

May 7, 2009

Hep C and Heavy Drinking Tied to Bone Fractures

Neither CD4 count and viral load, nor type of antiretroviral (ARV) treatment was associated with a higher risk for having a severe bone fracture in people living with HIV, but being coinfected with hepatitis C virus (HCV) and drinking five or more drinks per day were, according to a French study published in the May 15 issue of AIDS and reported by aidsmap.

A number of studies have found that HIV-positive people have higher rates of bone mineral loss—called osteopenia when it is mild and osteoporosis when it is more severe—than their HIV-negative peers. What remains unclear, however, is whether people with HIV—either with or without bone mineral deficits—face a higher risk of serious bone fractures. Additionally, researchers remain unsure of the reason for the higher rates of osteopenia and osteoporosis in people living with HIV. As a result, they’ve cast a wide net of possibilities, including a side effect of ARV therapy, smoking, alcohol consumption and HIV itself.

To determine the specific risk factors associated with serious bone fractures and osteoporosis among people living with HIV, Fidéline Collin, from the Université Victor Segalen Bordeaux, in France, and her colleagues examined the medical records of 1,281 HIV-positive patients enrolled in the ANRS CO8 APROCO-COPILOTE study. The study began in 1997 to determine the effectiveness of combination (ARV) therapy with protease inhibitors.

Between 1997 and 2007, there were 27 bone fractures in 26 patients that were severe enough to require hospitalization or to significantly limit mobility. The rate of new fractures each year was roughly equivalent to what would be expected in the general population of HIV-negative people. Most of the fractures, 81 percent, were caused by trauma such as a fall or accident, and 19 percent occurred while the person had been drinking heavily. Only four people had osteoporosis at the time of the fracture.

After controlling for a number of variables, researchers found that heavy alcohol consumption and infection with HCV were the most significant factors associated with serious bone fracture. People with HCV had a fracture rate that was nearly 3 times as high, and people who drank heavily were 3.6 times more likely to have a serious fracture. There was no difference in the rate of fractures based on age, sex, body mass index, viral load at the start of the study or the type of protease inhibitor used. People who had fractures were, on average, more likely to have a lower CD4 count at the start of the study, but this difference was not significant when the researchers controlled for other factors. The authors suggest that heavy alcohol consumption can increase risk behaviors leading to trauma and ultimately to osteoporosis, while HCV infection may weaken bones by causing a deficiency in vitamin D.

Search: bone fracture, osteopenia, osteoporosis, bone mineral, alcohol, hepatitis C virus, HCV, Fidéline Collin, APROCO-COPILOTE


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

CROI 2009
Montréal, Canada
February 8-11, 2009


48th Annual ICAAC/IDSA 46th Annual Meeting
Washington, DC
October 25-28, 2008


XVII International AIDS Conference
Mexico City, Mexico
August 3-8, 2008


more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2009 Smart + Strong. All Rights Reserved. Terms of use and Your privacy